GGrantIndex
← Leaderboards

Sandra Jane Gendler

Mayo Clinic Coll Of Med, Mayo Clinic Az

$9,892,000
Attributed
$9,892,000
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY200515
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$9,892,000 · 6

By mechanism

R01$8,255,260 · 4
P50$1,636,740 · 1
P20$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Mayo Clinic Coll Of Med, Mayo Clinic Az

Same institution · by research overlap

Others in their field

Top investigators on “Tumor

Research focus

TumorImmuneT-LymphocyteDesignCellsCancer VaccinesImmune SystemTumor AntigensTumor GrowthNatural ImmunosuppressionCarcinomaDendritic CellsCancer TherapyAntigensImmunotherapyResponseVaccinationCancer PatientBaseMucinsCytokineMalignant NeoplasmsImmune ResponseImmunization

Grant awards (31)

Role of IL-9 in Treg Biology and Tumor Immunity$340,300
R01 · FY2015 · CA · contact PI
Optimization of Tumor Vaccines for the Aged$276,092
R01 · FY2015 · CA · contact PI
Functional Study of Mucin MUC1$350,378
R01 · FY2014 · CA · contact PI
Role of IL-9 in Treg Biology and Tumor Immunity$330,091
R01 · FY2014 · CA · contact PI
Optimization of Tumor Vaccines for the Aged$268,752
R01 · FY2014 · CA · contact PI
Functional Study of Mucin MUC1$339,542
R01 · FY2013 · CA · contact PI
Role of IL-9 in Treg Biology and Tumor Immunity$319,882
R01 · FY2013 · CA · contact PI
Optimization of Tumor Vaccines for the Aged$264,235
R01 · FY2013 · CA · contact PI
Functional Study of Mucin MUC1$361,215
R01 · FY2012 · CA · contact PI
Role of IL-9 in Treg Biology and Tumor Immunity$340,300
R01 · FY2012 · CA · contact PI
Optimization of Tumor Vaccines for the Aged$281,101
R01 · FY2012 · CA · contact PI
Functional Study of Mucin MUC1$361,215
R01 · FY2011 · CA · contact PI
Role of IL-9 in Treg Biology and Tumor Immunity$340,300
R01 · FY2011 · CA · contact PI
Mechanism of Action of CpG-ODN in Generating Tumor Immunity in the Aged$301,099
R01 · FY2011 · AG · contact PI
Optimization of Tumor Vaccines for the Aged$279,268
R01 · FY2011 · CA · contact PI
Functional Study of Mucin MUC1$372,387
R01 · FY2010 · CA · contact PI
Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in Breas$373,582
P50 · FY2009 · CA · contact PI
Functional Study of a Carcinoma Associated Mucin MUC1$346,110
R01 · FY2008 · CA · contact PI
Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in Breas$285,322
P50 · FY2008 · CA · contact PI
P-3: Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in$393,936
P50 · FY2007 · CA · contact PI
Functional Study of a Carcinoma Associated Mucin MUC1$346,110
R01 · FY2007 · CA · contact PI
Functional Study of a Carcinoma Associated Mucin MUC1$356,447
R01 · FY2006 · CA · contact PI
P-3: Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in$296,243
P50 · FY2006 · CA · contact PI
Functional Study of a Carcinoma Associated Mucin MUC1$365,025
R01 · FY2005 · CA
P-3: Preclinical and Clinical Studies of MUC1 Glycopeptide Vaccine Strategies in$287,657
P50 · FY2005 · CA
Functional Study of a Carcinoma Associated Mucin MUC1$365,025
R01 · FY2004 · CA
FUNCTIONAL STUDY OF A CARCINOMA ASSOCIATED MUCIN MUC1$353,044
R01 · FY2003 · CA
Core--Animal models and xenograft$0
P20 · FY2003 · CA
FUNCTIONAL STUDY OF A CARCINOMA ASSOCIATED MUCIN MUC1$342,705
R01 · FY2002 · CA
FUNCTIONAL STUDY OF A CARCINOMA ASSOCIATED MUCIN MUC1$342,180
R01 · FY2001 · CA
FUNCTIONAL STUDY OF A CARCINOMA ASSOCIATED MUCIN MUC1$312,457
R01 · FY2000 · CA